Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation

Cancer

Volumn 85, Issue 8, 1999, Pages 1822-1827

  Matsushima, Hisashi ^a   Goto, Toshitaka ^b   Hosaka, Yoshio ^b   Kitamura, Tadaichi ^b   Kawabe, Kazuki ^b  

^a Tokyo Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Androgen ablation; Angiogenesis; Apoptosis; Immunohistochemistry; Microvessel density; Neoadjuvant hormonal therapy; Proliferation; Prostate neoplasms; Terminal deoxynucleotidyl transferase mediated dUTP biotin nick end labeling

Indexed keywords

FLUTAMIDE; GONADORELIN AGONIST; KI 67 ANTIGEN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA; REGRESSION ANALYSIS; TUMOR VASCULARIZATION;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; ANDROGENS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, HORMONAL; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FLUTAMIDE; GONADOTROPIN-RELEASING HORMONE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; NEOVASCULARIZATION, PATHOLOGIC; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0033561382     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1822::AID-CNCR24>3.0.CO;2-1     Document Type: Article

References (22)

1. Tu H, Jacobs SC, Borkowski A, Kyprianou N. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-betal and bcl-2 expression. Int J Cancer 1996;69:357-63.
2. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling. Int J Cancer 1996;65:173-7.
3. Aihara M, Truong LD, Dunn JK, Wheeler TM, Scardino PT, Thompson TC. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol 1994;25:797-801.
4. Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996;48:47-57.
5. Brawer MK. Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma. Cancer 1996;78:345-9.
6. Lissbrant IF, Stattin P, Damber JE, Bergh A. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 1997;33:38-45.
7. Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1997;79:772-9.
8. Tipoe GL, Jin Y, White FH. The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium. Eur J Cancer 1996; 1:24-31.
9. Vermeulen PB, Verhoeven D, Hubens G, Van Marck E, Goovaerts G, Huyghe M, et al. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol 1995;6:59-64.
10. Lu C, Tanigawa N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res 1997;57:221-4.
11. Vukanovic J, Isaacs JT. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide. Cancer Res 1995;55: 3517-20.
12. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z. Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry 1994;15:169-75.
13. Colecchia M, Frigo B, Del Boca C, Guardamagna A, Zucchi A, Colloi D, et al. Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy. J Clin Pathol 1997;50: 384-8.
14. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990;43:752-7.
15. Montironi R, Schulman C. Pathological changes in prostatic lesions after androgen manipulation. J Clin Pathol 1998;51: 5-12.
16. Montironi R, Magi Galluzzi CM, Marina S, Diamanti L. Quantitative characterization of the frequency and location of cell proliferation and death in prostate pathology. J Cell Biochem 1994;19:238-45.
17. Shi S, Key M, Ralra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39: 741-8.
18. Gavrieli Y, Sherman Y, Ben-Sasson S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
19. Weidner N, Semple J, Welch W, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324(1):1-8.
20. Bubendorf L, Sauter G, Moch H, Schmid HP, Gasser TC, Jordan P, et al. Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol 1996;178:437-41.
21. Wheeler TM, Rogers E, Aihara M, Scardino PT, Thompson TC. Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer. J Cell Biochem 1994;19:202-7.
22. Brown C, Sauvageot J, Kahane H, Epstein JI. Cell proliferation and apoptosis in prostate cancer-correlation with pathologie stage? Mod Pathol 1996;9:205-9.